Annual Shareholders Equity
$57.30 M
+$26.24 M+84.49%
31 December 2023
Summary:
SAB Biotherapeutics annual stockholders equity is currently $57.30 million, with the most recent change of +$26.24 million (+84.49%) on 31 December 2023. During the last 3 years, it has risen by +$18.29 million (+46.89%). SABS annual shareholders equity is now at all-time high.SABS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$36.90 M
-$9.22 M-19.99%
30 September 2024
Summary:
SAB Biotherapeutics quarterly stockholders equity is currently $36.90 million, with the most recent change of -$9.22 million (-19.99%) on 30 September 2024. Over the past year, it has increased by +$21.65 million (+141.89%). SABS quarterly shareholders equity is now -65.47% below its all-time high of $106.86 million, reached on 30 September 2021.SABS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +84.5% | +141.9% |
| 3 y3 years | +46.9% | -65.5% |
| 5 y5 years | - | - |
SABS Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +84.5% | -65.5% | +141.9% |
| 5 y | 5 years | at high | +2585.2% | -65.5% | +141.9% |
| alltime | all time | at high | +2585.2% | -65.5% | +141.9% |
SAB Biotherapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $36.90 M(-20.0%) |
| June 2024 | - | $46.12 M(-12.7%) |
| Mar 2024 | - | $52.82 M(-7.8%) |
| Dec 2023 | $57.30 M(+84.5%) | $57.30 M(+275.6%) |
| Sept 2023 | - | $15.26 M(-22.6%) |
| June 2023 | - | $19.72 M(-19.2%) |
| Mar 2023 | - | $24.40 M(-21.4%) |
| Dec 2022 | $31.06 M | $31.06 M(+1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $30.62 M(-17.5%) |
| June 2022 | - | $37.12 M(-10.0%) |
| Mar 2022 | - | $41.26 M(+7.0%) |
| Dec 2021 | $38.55 M(-1.2%) | $38.55 M(-63.9%) |
| Sept 2021 | - | $106.86 M(+179.3%) |
| June 2021 | - | $38.26 M(-1.9%) |
| Dec 2020 | $39.01 M(-1791.9%) | $39.01 M |
| Dec 2019 | -$2.31 M | - |
FAQ
- What is SAB Biotherapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual shareholders equity year-on-year change?
- What is SAB Biotherapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly shareholders equity year-on-year change?
What is SAB Biotherapeutics annual stockholders equity?
The current annual shareholders equity of SABS is $57.30 M
What is the all time high annual shareholders equity for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual stockholders equity is $57.30 M
What is SAB Biotherapeutics annual shareholders equity year-on-year change?
Over the past year, SABS annual stockholders equity has changed by +$26.24 M (+84.49%)
What is SAB Biotherapeutics quarterly stockholders equity?
The current quarterly shareholders equity of SABS is $36.90 M
What is the all time high quarterly shareholders equity for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly stockholders equity is $106.86 M
What is SAB Biotherapeutics quarterly shareholders equity year-on-year change?
Over the past year, SABS quarterly stockholders equity has changed by +$21.65 M (+141.89%)